493 related articles for article (PubMed ID: 33303976)
1. E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer.
Morgan EL; Scarth JA; Patterson MR; Wasson CW; Hemingway GC; Barba-Moreno D; Macdonald A
Cell Death Differ; 2021 May; 28(5):1669-1687. PubMed ID: 33303976
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of PIR gene expression induced by human papillomavirus E6 and E7 in epithelial oral and cervical cells.
Carrillo D; Muñoz JP; Huerta H; Leal G; Corvalán A; León O; Calaf GM; Urzúa U; Boccardo E; Tapia JC; Aguayo F
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118270
[TBL] [Abstract][Full Text] [Related]
3. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
4. Dickkopf-1 expression is repressed by oncogenic human papillomaviruses (HPVs) and regulates the Cisplatin sensitivity of HPV-positive cancer cells in a JNK-dependent manner.
Frensemeier K; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2022 Dec; 151(12):2215-2228. PubMed ID: 36094276
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
7. Wnt-11 overexpression promoting the invasion of cervical cancer cells.
Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang S
Tumour Biol; 2016 Sep; 37(9):11789-11798. PubMed ID: 27034261
[TBL] [Abstract][Full Text] [Related]
8. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
9. E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
Patterson MR; Meijers AS; Ryder EL; Scarth JA; Evans D; Turner AL; Wasson CW; Darell JE; Theobald D; Cogan J; James CD; Wang M; Ladbury JE; Morgan IM; Samson A; Morgan EL; Macdonald A
bioRxiv; 2024 Jan; ():. PubMed ID: 38293147
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.
Bousarghin L; Touze A; Gaud G; Iochmann S; Alvarez E; Reverdiau P; Gaitan J; Jourdan ML; Sizaret PY; Coursaget PL
Mol Cancer Ther; 2009 Feb; 8(2):357-65. PubMed ID: 19174559
[TBL] [Abstract][Full Text] [Related]
11. Exploitation of ATP-sensitive potassium ion (K
Scarth JA; Wasson CW; Patterson MR; Evans D; Barba-Moreno D; Carden H; Cassidy R; Whitehouse A; Mankouri J; Samson A; Morgan EL; Macdonald A
Oncogene; 2023 Aug; 42(34):2558-2577. PubMed ID: 37443304
[TBL] [Abstract][Full Text] [Related]
12. CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation.
Li Y; Patterson MR; Morgan EL; Wasson CW; Ryder EL; Barba-Moreno D; Scarth JA; Wang M; Macdonald A
J Med Virol; 2023 Aug; 95(8):e29025. PubMed ID: 37565725
[TBL] [Abstract][Full Text] [Related]
13. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
15. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
16. The role of globular heads of the C1q receptor in HPV 16 E2-induced human cervical squamous carcinoma cell apoptosis is associated with p38 MAPK/JNK activation.
Gao LJ; Gu PQ; Zhao W; Ding WY; Zhao XQ; Guo SY; Zhong TY
J Transl Med; 2013 May; 11():118. PubMed ID: 23651874
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
[TBL] [Abstract][Full Text] [Related]
18. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
19. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
20. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the
Chen X; Loo JX; Shi X; Xiong W; Guo Y; Ke H; Yang M; Jiang Y; Xia S; Zhao M; Zhong S; He C; Fu L; Li F
Cancer Res; 2018 Mar; 78(6):1418-1430. PubMed ID: 29339538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
